Global Avanafil (CAS 330784-47-9) Market Report 2019, Competitive Landscape, Trends and Opportunities
The Avanafil (CAS 330784-47-9) market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Avanafil (CAS 330784-47-9) market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Avanafil (CAS 330784-47-9) market.
Major players in the global Avanafil (CAS 330784-47-9) market include:
JW Pharmaceutical
VIVUS
Menarini Group
Sanofi
Endo International
Auxilium Pharmaceuticals, Inc
On the basis of types, the Avanafil (CAS 330784-47-9) market is primarily split into:
50mg
100mg
200mg
Other
On the basis of applications, the market covers:
Healthcare
Treatment
Other
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Avanafil (CAS 330784-47-9) market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Avanafil (CAS 330784-47-9) market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Avanafil (CAS 330784-47-9) industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Avanafil (CAS 330784-47-9) market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Avanafil (CAS 330784-47-9), by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Avanafil (CAS 330784-47-9) in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Avanafil (CAS 330784-47-9) in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Avanafil (CAS 330784-47-9). Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Avanafil (CAS 330784-47-9) market, including the global production and revenue forecast, regional forecast. It also foresees the Avanafil (CAS 330784-47-9) market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Avanafil (CAS 330784-47-9) market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Avanafil (CAS 330784-47-9) market.
Major players in the global Avanafil (CAS 330784-47-9) market include:
JW Pharmaceutical
VIVUS
Menarini Group
Sanofi
Endo International
Auxilium Pharmaceuticals, Inc
On the basis of types, the Avanafil (CAS 330784-47-9) market is primarily split into:
50mg
100mg
200mg
Other
On the basis of applications, the market covers:
Healthcare
Treatment
Other
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Avanafil (CAS 330784-47-9) market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Avanafil (CAS 330784-47-9) market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Avanafil (CAS 330784-47-9) industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Avanafil (CAS 330784-47-9) market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Avanafil (CAS 330784-47-9), by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Avanafil (CAS 330784-47-9) in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Avanafil (CAS 330784-47-9) in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Avanafil (CAS 330784-47-9). Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Avanafil (CAS 330784-47-9) market, including the global production and revenue forecast, regional forecast. It also foresees the Avanafil (CAS 330784-47-9) market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 AVANAFIL (CAS 330784-47-9) MARKET OVERVIEW
1.1 Product Overview and Scope of Avanafil (CAS 330784-47-9)
1.2 Avanafil (CAS 330784-47-9) Segment by Type
1.2.1 Global Avanafil (CAS 330784-47-9) Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of 50mg
1.2.3 The Market Profile of 100mg
1.2.4 The Market Profile of 200mg
1.2.5 The Market Profile of Other
1.3 Global Avanafil (CAS 330784-47-9) Segment by Application
1.3.1 Avanafil (CAS 330784-47-9) Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Healthcare
1.3.3 The Market Profile of Treatment
1.3.4 The Market Profile of Other
1.4 Global Avanafil (CAS 330784-47-9) Market by Region (2014-2026)
1.4.1 Global Avanafil (CAS 330784-47-9) Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3 Europe Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.1 Germany Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.2 UK Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.3 France Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.4 Italy Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.5 Spain Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.6 Russia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.7 Poland Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.4 China Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.5 Japan Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.6 India Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.8 Central and South America Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Avanafil (CAS 330784-47-9) (2014-2026)
1.5.1 Global Avanafil (CAS 330784-47-9) Revenue Status and Outlook (2014-2026)
1.5.2 Global Avanafil (CAS 330784-47-9) Production Status and Outlook (2014-2026)
2 GLOBAL AVANAFIL (CAS 330784-47-9) MARKET LANDSCAPE BY PLAYER
2.1 Global Avanafil (CAS 330784-47-9) Production and Share by Player (2014-2019)
2.2 Global Avanafil (CAS 330784-47-9) Revenue and Market Share by Player (2014-2019)
2.3 Global Avanafil (CAS 330784-47-9) Average Price by Player (2014-2019)
2.4 Avanafil (CAS 330784-47-9) Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Avanafil (CAS 330784-47-9) Market Competitive Situation and Trends
2.5.1 Avanafil (CAS 330784-47-9) Market Concentration Rate
2.5.2 Avanafil (CAS 330784-47-9) Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 JW Pharmaceutical
3.1.1 JW Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.1.3 JW Pharmaceutical Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.1.4 JW Pharmaceutical Business Overview
3.2 VIVUS
3.2.1 VIVUS Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.2.3 VIVUS Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.2.4 VIVUS Business Overview
3.3 Menarini Group
3.3.1 Menarini Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.3.3 Menarini Group Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.3.4 Menarini Group Business Overview
3.4 Sanofi
3.4.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.4.3 Sanofi Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.4.4 Sanofi Business Overview
3.5 Endo International
3.5.1 Endo International Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.5.3 Endo International Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.5.4 Endo International Business Overview
3.6 Auxilium Pharmaceuticals, Inc
3.6.1 Auxilium Pharmaceuticals, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.6.3 Auxilium Pharmaceuticals, Inc Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.6.4 Auxilium Pharmaceuticals, Inc Business Overview
4 GLOBAL AVANAFIL (CAS 330784-47-9) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Avanafil (CAS 330784-47-9) Production and Market Share by Type (2014-2019)
4.2 Global Avanafil (CAS 330784-47-9) Revenue and Market Share by Type (2014-2019)
4.3 Global Avanafil (CAS 330784-47-9) Price by Type (2014-2019)
4.4 Global Avanafil (CAS 330784-47-9) Production Growth Rate by Type (2014-2019)
4.4.1 Global Avanafil (CAS 330784-47-9) Production Growth Rate of 50mg (2014-2019)
4.4.2 Global Avanafil (CAS 330784-47-9) Production Growth Rate of 100mg (2014-2019)
4.4.3 Global Avanafil (CAS 330784-47-9) Production Growth Rate of 200mg (2014-2019)
4.4.4 Global Avanafil (CAS 330784-47-9) Production Growth Rate of Other (2014-2019)
5 GLOBAL AVANAFIL (CAS 330784-47-9) MARKET ANALYSIS BY APPLICATION
5.1 Global Avanafil (CAS 330784-47-9) Consumption and Market Share by Application (2014-2019)
5.2 Global Avanafil (CAS 330784-47-9) Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Avanafil (CAS 330784-47-9) Consumption Growth Rate of Healthcare (2014-2019)
5.2.2 Global Avanafil (CAS 330784-47-9) Consumption Growth Rate of Treatment (2014-2019)
5.2.3 Global Avanafil (CAS 330784-47-9) Consumption Growth Rate of Other (2014-2019)
6 GLOBAL AVANAFIL (CAS 330784-47-9) PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Avanafil (CAS 330784-47-9) Consumption by Region (2014-2019)
6.2 United States Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.3 Europe Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.4 China Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.5 Japan Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.6 India Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
7 GLOBAL AVANAFIL (CAS 330784-47-9) PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Avanafil (CAS 330784-47-9) Production and Market Share by Region (2014-2019)
7.2 Global Avanafil (CAS 330784-47-9) Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
8 AVANAFIL (CAS 330784-47-9) MANUFACTURING ANALYSIS
8.1 Avanafil (CAS 330784-47-9) Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Avanafil (CAS 330784-47-9)
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Avanafil (CAS 330784-47-9) Industrial Chain Analysis
9.2 Raw Materials Sources of Avanafil (CAS 330784-47-9) Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Avanafil (CAS 330784-47-9)
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL AVANAFIL (CAS 330784-47-9) MARKET FORECAST (2019-2026)
11.1 Global Avanafil (CAS 330784-47-9) Production, Revenue Forecast (2019-2026)
11.1.1 Global Avanafil (CAS 330784-47-9) Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Avanafil (CAS 330784-47-9) Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Avanafil (CAS 330784-47-9) Price and Trend Forecast (2019-2026)
11.2 Global Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Avanafil (CAS 330784-47-9) Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Avanafil (CAS 330784-47-9) Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Avanafil (CAS 330784-47-9)
1.2 Avanafil (CAS 330784-47-9) Segment by Type
1.2.1 Global Avanafil (CAS 330784-47-9) Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of 50mg
1.2.3 The Market Profile of 100mg
1.2.4 The Market Profile of 200mg
1.2.5 The Market Profile of Other
1.3 Global Avanafil (CAS 330784-47-9) Segment by Application
1.3.1 Avanafil (CAS 330784-47-9) Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Healthcare
1.3.3 The Market Profile of Treatment
1.3.4 The Market Profile of Other
1.4 Global Avanafil (CAS 330784-47-9) Market by Region (2014-2026)
1.4.1 Global Avanafil (CAS 330784-47-9) Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3 Europe Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.1 Germany Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.2 UK Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.3 France Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.4 Italy Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.5 Spain Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.6 Russia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.3.7 Poland Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.4 China Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.5 Japan Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.6 India Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.8 Central and South America Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Avanafil (CAS 330784-47-9) Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Avanafil (CAS 330784-47-9) (2014-2026)
1.5.1 Global Avanafil (CAS 330784-47-9) Revenue Status and Outlook (2014-2026)
1.5.2 Global Avanafil (CAS 330784-47-9) Production Status and Outlook (2014-2026)
2 GLOBAL AVANAFIL (CAS 330784-47-9) MARKET LANDSCAPE BY PLAYER
2.1 Global Avanafil (CAS 330784-47-9) Production and Share by Player (2014-2019)
2.2 Global Avanafil (CAS 330784-47-9) Revenue and Market Share by Player (2014-2019)
2.3 Global Avanafil (CAS 330784-47-9) Average Price by Player (2014-2019)
2.4 Avanafil (CAS 330784-47-9) Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Avanafil (CAS 330784-47-9) Market Competitive Situation and Trends
2.5.1 Avanafil (CAS 330784-47-9) Market Concentration Rate
2.5.2 Avanafil (CAS 330784-47-9) Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 JW Pharmaceutical
3.1.1 JW Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.1.3 JW Pharmaceutical Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.1.4 JW Pharmaceutical Business Overview
3.2 VIVUS
3.2.1 VIVUS Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.2.3 VIVUS Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.2.4 VIVUS Business Overview
3.3 Menarini Group
3.3.1 Menarini Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.3.3 Menarini Group Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.3.4 Menarini Group Business Overview
3.4 Sanofi
3.4.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.4.3 Sanofi Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.4.4 Sanofi Business Overview
3.5 Endo International
3.5.1 Endo International Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.5.3 Endo International Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.5.4 Endo International Business Overview
3.6 Auxilium Pharmaceuticals, Inc
3.6.1 Auxilium Pharmaceuticals, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Avanafil (CAS 330784-47-9) Product Profiles, Application and Specification
3.6.3 Auxilium Pharmaceuticals, Inc Avanafil (CAS 330784-47-9) Market Performance (2014-2019)
3.6.4 Auxilium Pharmaceuticals, Inc Business Overview
4 GLOBAL AVANAFIL (CAS 330784-47-9) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Avanafil (CAS 330784-47-9) Production and Market Share by Type (2014-2019)
4.2 Global Avanafil (CAS 330784-47-9) Revenue and Market Share by Type (2014-2019)
4.3 Global Avanafil (CAS 330784-47-9) Price by Type (2014-2019)
4.4 Global Avanafil (CAS 330784-47-9) Production Growth Rate by Type (2014-2019)
4.4.1 Global Avanafil (CAS 330784-47-9) Production Growth Rate of 50mg (2014-2019)
4.4.2 Global Avanafil (CAS 330784-47-9) Production Growth Rate of 100mg (2014-2019)
4.4.3 Global Avanafil (CAS 330784-47-9) Production Growth Rate of 200mg (2014-2019)
4.4.4 Global Avanafil (CAS 330784-47-9) Production Growth Rate of Other (2014-2019)
5 GLOBAL AVANAFIL (CAS 330784-47-9) MARKET ANALYSIS BY APPLICATION
5.1 Global Avanafil (CAS 330784-47-9) Consumption and Market Share by Application (2014-2019)
5.2 Global Avanafil (CAS 330784-47-9) Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Avanafil (CAS 330784-47-9) Consumption Growth Rate of Healthcare (2014-2019)
5.2.2 Global Avanafil (CAS 330784-47-9) Consumption Growth Rate of Treatment (2014-2019)
5.2.3 Global Avanafil (CAS 330784-47-9) Consumption Growth Rate of Other (2014-2019)
6 GLOBAL AVANAFIL (CAS 330784-47-9) PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Avanafil (CAS 330784-47-9) Consumption by Region (2014-2019)
6.2 United States Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.3 Europe Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.4 China Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.5 Japan Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.6 India Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Avanafil (CAS 330784-47-9) Production, Consumption, Export, Import (2014-2019)
7 GLOBAL AVANAFIL (CAS 330784-47-9) PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Avanafil (CAS 330784-47-9) Production and Market Share by Region (2014-2019)
7.2 Global Avanafil (CAS 330784-47-9) Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Avanafil (CAS 330784-47-9) Production, Revenue, Price and Gross Margin (2014-2019)
8 AVANAFIL (CAS 330784-47-9) MANUFACTURING ANALYSIS
8.1 Avanafil (CAS 330784-47-9) Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Avanafil (CAS 330784-47-9)
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Avanafil (CAS 330784-47-9) Industrial Chain Analysis
9.2 Raw Materials Sources of Avanafil (CAS 330784-47-9) Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Avanafil (CAS 330784-47-9)
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL AVANAFIL (CAS 330784-47-9) MARKET FORECAST (2019-2026)
11.1 Global Avanafil (CAS 330784-47-9) Production, Revenue Forecast (2019-2026)
11.1.1 Global Avanafil (CAS 330784-47-9) Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Avanafil (CAS 330784-47-9) Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Avanafil (CAS 330784-47-9) Price and Trend Forecast (2019-2026)
11.2 Global Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Avanafil (CAS 330784-47-9) Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Avanafil (CAS 330784-47-9) Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Avanafil (CAS 330784-47-9) Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
